| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/03/2005 | EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 08/03/2005 | EP1330166B1 Food grade transglutaminase inhibitor and uses thereof |
| 08/03/2005 | EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 08/03/2005 | EP1282438B1 Use of pharmaceutical composition comprising a factor viia and a factor xiii |
| 08/03/2005 | EP1142890B1 Aminopyrazole derivatives |
| 08/03/2005 | EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/03/2005 | EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 08/03/2005 | CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 08/03/2005 | CN1649879A Non-steroidal progesterone receptor modulators |
| 08/03/2005 | CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649849A Tachykinin receptor antagonists |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649601A Difructose anhydride-containing composition and use thereof |
| 08/03/2005 | CN1648134A Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 08/03/2005 | CN1213143C Pharmacentical use of homoeotic hematoietic system reconstitution cell |
| 08/03/2005 | CN1213056C Structure and uses of autisense oligodeoxynucleotide for treating thrombus disease |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213029C S-Ht receptor agonist and its preparing method for salt |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/03/2005 | CN1212850C Oral liquid for resolving embolism |
| 08/03/2005 | CN1212846C Preparing process of anticoagulant konjak glucomanan sulfate |
| 08/03/2005 | CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors |
| 08/03/2005 | CN1212831C Pharmaceutical preparations |
| 08/03/2005 | CN1212830C Delivery of solid drug compositions |
| 08/02/2005 | US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy |
| 08/02/2005 | US6924356 Human protein HHEPU32 |
| 08/02/2005 | US6924314 Compounds for the treatment of metabolic disorders |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924296 Antithrombotic agents |
| 08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6924151 Binding particles; for use in the treatment of blood disorders |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities |
| 08/02/2005 | CA2154577C Novel inhibitors of adenosine monophosphate deaminase |
| 08/02/2005 | CA2118121C Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 07/30/2005 | CA2495048A1 Hemostatic compositions and devices |
| 07/28/2005 | WO2005067970A1 Iron supplement and utilization of the same |
| 07/28/2005 | WO2004033620A3 Methods and compositions for therapeutic use of rna interference |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | US20050165113 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 07/28/2005 | US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants |
| 07/28/2005 | US20050165030 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/28/2005 | US20050165021 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164989 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164964 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164927 Aqueous sustained-release formulations of proteins |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164366 Tissue plasminogen activator-like protease |
| 07/28/2005 | US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552889A1 Iron supplement and utilization of the same |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557407A1 Novel alpha-ketoamide derivative and use thereof |
| 07/27/2005 | EP1557183A1 Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis |
| 07/27/2005 | EP1556705A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 07/27/2005 | EP1556414A1 Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556379A2 Chemical compounds |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556129A2 Compositions and methods for inducing osteogenesis |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556027A1 Modified amino acid for the inhibition of platelet aggregation |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1185527B1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 07/27/2005 | EP1133489B1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 07/27/2005 | EP0831888B1 Methods for increasing hematopoietic cells |
| 07/27/2005 | CN1646568A Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 07/27/2005 | CN1646564A 修饰的因子Ⅷ Modification factor Ⅷ |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646485A Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 07/27/2005 | CN1646162A Use of an inhibitor or antagonist against tissue factor |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646146A Methods of treating vascular disease |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646118A Pharmaceutical composition for preventing or treating respiratory disease |